Overview

Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This is a phase 1, open-label study designed to determine the interaction of rifampin with linifanib.
Phase:
Phase 1
Details
Lead Sponsor:
Abbott
Treatments:
Rifampin